South Dakota Small Cannabis Operators Face a Compliance Cliff: Federal Rescheduling Likely to Drive More Closures and Force Consolidation

The collapse of recreational legalization efforts in South Dakota already triggered a wave of dispensary closures. At least eight licensed medical cannabis businesses shuttered in late 2024 and early 2025 amid falling cardholder numbers, intense price competition, and regulatory pressures.¹ “Then it was a race to the bottom on pricing,” one industry participant observed as margins evaporated.² These closures were not isolated failures; they were early warnings of what happens when an industry built on limited competition and state-only rules collides with broader market and regulatory realities.

The April 28, 2026, federal partial rescheduling order (placing certain FDA-approved and state-licensed medical marijuana products into Schedule III) introduces a new and more demanding compliance regime.³ State-licensed operators seeking to operate lawfully under the new federal framework must obtain DEA registration. This requires detailed security protocols, diversion-prevention plans, recordkeeping systems, inventory controls, and compliance history disclosures—obligations with no direct analog in South Dakota’s existing medical program.⁴ Application fees, legal and consulting costs (often estimated in the $10,000–$15,000 range for preparation alone), facility upgrades, and ongoing inspection readiness add substantial capital and administrative burdens.⁵

These costs will not fall evenly. Larger, well-capitalized operators with vertical integration, professional compliance infrastructure, and access to financing—such as 605 Cannabis and Genesis Farms—are far better positioned to absorb the expense and meet federal standards. Smaller, independent operators without those resources face a genuine compliance cliff. One detailed industry analysis concluded that “the increased DEA compliance costs will partially offset the tax savings achieved by 280E’s nullification. This will increase capital and administrative expenditures, which could put smaller operators at a long-term disadvantage.”⁶

Much of the public policy commentary and guidance circulating in South Dakota’s cannabis community originates from business leaders, trade associations, and operators with significant financial stakes in the existing market structure. This creates an inherent incentive to emphasize opportunity and downplay structural risks. Optimistic messaging protects short-term investor sentiment and business positioning, but it can leave smaller operators underprepared for the capital intensity and operational overhauls required under federal Schedule III rules. Policy analysis shaped primarily by those with the resources to survive consolidation risks becoming systematically biased toward the interests of larger players.

The Private Reckoning: What Two Out-of-State Consultants Most Likely Taught South Dakota Operators Behind Closed Doors

Small operators – throughout the country – should therefore treat consolidation—not just survival—as a realistic strategic option in the coming years. Businesses that cannot independently meet escalating federal security, recordkeeping, manufacturing, and distribution standards may need to explore mergers, acquisitions, or strategic partnerships to achieve the scale and infrastructure necessary for compliance. Ignoring this reality in favor of generic assurances that “we’ll figure it out” does a disservice to owners who have invested years building legitimate operations.

This is not a prediction of universal doom. It is a warning meant to offer clear-eyed guidance. The federal changes create real pathways for legitimacy, tax relief for compliant operators, and long-term industry stabilization. But those benefits are gated behind compliance capacity that many small businesses currently lack. Operators who assess their position honestly now—reviewing capital reserves, compliance infrastructure, and realistic timelines—will be better positioned to make deliberate decisions rather than reactive ones.

Importantly, even if a small operator ultimately exits the cultivation or dispensary side of the business, that outcome does not represent personal or professional failure. It can free individuals to pivot into areas of genuine need: advocating for patients in rural communities or those with limited income who still face access barriers; educating patients and healthcare providers on safe, evidence-based use; or building ancillary businesses (testing, compliance consulting, education platforms, or supply-chain services) that strengthen the broader ecosystem. The industry’s evolution creates space for new roles that serve patients directly and support a more professional, transparent market.

South Dakota’s cannabis program has already experienced consolidation pressure from the recreational failure. Federal rescheduling will intensify that dynamic. Small operators who treat the compliance requirements as a serious operational and financial challenge—rather than something that will simply resolve itself—will be best equipped to navigate the transition, whether that means adapting, consolidating, or pivoting to other valuable work in service of patients and the industry’s long-term integrity.

Federal Changes Do Not Mean South Dakota Will Simply Leave Cannabis Operators Alone

Footnotes

¹ South Dakota Searchlight, “Medical dispensaries are closing after SD’s rejection of recreational marijuana,” Dec. 27, 2024, https://southdakotasearchlight.com/2024/12/27/medical-dispensaries-are-closing-after-sds-rejection-of-recreational-marijuana/ (documenting at least eight shuttered dispensaries).

² Id. (quoting industry participant on pricing pressure following recreational measure failure).

³ Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements, 91 Fed. Reg. 22714 (Apr. 28, 2026) (2026-08176).

⁴ Id. at 22719 (requiring DEA registration for any person handling covered marijuana products and detailing security, recordkeeping, and closed-system distribution obligations).

⁵ KVK Lawyers, “The DOJ’s Cannabis Rescheduling Order: Understanding the Next Steps for Operators” (May 1, 2026), https://www.kvklawyers.com/2026/05/01/the-dojs-cannabis-rescheduling-order-understanding-the-next-steps-for-operators/ (discussing application requirements, fees, and compliance protocols for state-licensed operators).

⁶ Abraham Finberg & Simon Menkes, “Cannabis Rescheduling’s Compliance Costs Will Dent Tax Savings,” Bloomberg Tax, Apr. 28, 2026, https://news.bloombergtax.com/tax-insights-and-commentary/cannabis-reschedulings-compliance-costs-will-dent-tax-savings (analyzing how DEA compliance burdens disproportionately affect smaller operators relative to tax relief).

⁷ See, e.g., Foley & Lardner LLP, “Marijuana – Some Products Reclassified to Schedule III: What It Means, What It Doesn’t, and What Comes Next” (Apr. 23, 2026) (noting substantial capital investment and operational overhauls required for compliance that smaller operators may struggle to complete in time).

⁸ See 91 Fed. Reg. at 22719–22720 (establishing registration, security, and recordkeeping framework that increases fixed compliance costs).

⁹ Industry analyses have repeatedly documented that rescheduling pathways favor operators with existing scale and professional infrastructure, accelerating market concentration. See, e.g., reports from Headset and Vangst on post-rescheduling operator impact modeling (widely cited in 2026 transition commentary).

¹⁰ The tax relief associated with removal of 280E restrictions for qualifying Schedule III operations is real but accessible only to those who successfully navigate DEA registration and ongoing federal compliance obligations. See Bloomberg Tax, supra note 6.

¹¹ Much public commentary from industry-aligned voices has emphasized opportunity while giving limited attention to the capital and operational thresholds that will determine which businesses can actually participate in the new federal framework.

¹² Operators facing closure or consolidation should view the transition as an opportunity to redirect expertise toward patient advocacy, education, rural access initiatives, provider training, or ancillary services that address documented gaps in the evolving market—roles that remain essential regardless of any single business’s operational status.

This piece is written as a substantive warning grounded in documented market patterns and specific regulatory requirements. It is intended to help small operators make informed decisions rather than rely on selective optimism. The record of prior closures after recreational efforts failed, combined with the concrete compliance obligations now emerging from federal rescheduling, supports treating these pressures as real and actionable.